Mehrukh Zehravi | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Mehrukh Zehravi | Toxicology and Pharmaceutical Science | Best Researcher Award

Buraydah Private colleges, Saudi Arabia

She is a highly motivated and experienced Clinical Pharmacy lecturer with a proven track record of delivering engaging and effective teaching to both undergraduate and graduate students. With in-depth knowledge of Clinical Pharmacy, therapeutics, medication management, patient counseling, and drug safety, she excels in developing and delivering curricula, supervising practical training sessions, and conducting research to advance the field of clinical pharmacy. She collaborates effectively with other healthcare professionals to improve patient care and outcomes. A passionate and dedicated educator, she is committed to providing students with the knowledge and skills they need to succeed in their careers as pharmacists.

Professional Profile

Education

She is currently pursuing a Ph.D. in Pharmaceutical Sciences at the University of Karachi, Pakistan, expected to complete in 2025. She holds a Master’s in Pharmaceutical Sciences, earned between August 2007 and December 2009, and a Bachelor of Pharmacy, completed between January 2002 and December 2005, both from the University of Karachi. Throughout her career, she has received a letter of appreciation from the University for her on-field Pharmacy Training from 2016 to 2023. She designed and implemented a new clinical pharmacy curriculum that enhanced student learning and engagement, leading to improved student performance and feedback. She has published multiple research articles in high-impact, peer-reviewed journals, demonstrating her expertise in clinical pharmacy and contributing to the field’s advancement. Additionally, she has mentored and supervised graduate students in clinical pharmacy research, helping them develop their research skills and publish their work in reputable journal

Professional Experience

She has actively participated in various conferences and workshops to enhance her professional development. In 2016, she attended a workshop on “Coaching Conversation Approaches for the Workplace” at Prince Sattam Bin Abdul Aziz University. She also participated in the conference on “WHO Prescribing Indicators & Its Compliance by General Practitioners of Lahore, Pakistan,” conducted by the 4th China Pharmaceutical University International Students Academic Forum at the Conference Center Jiangning Campus in April 2017. She attended the PPA International Conference Seminar on “Pharmacists Voice: Patient Safety Starts with Me” at the University of Central Punjab, Pakistan. Additionally, she was involved in the 3rd Annual Conference of Rashid Latif College of Pharmacy, held at Rashid Latif Medical College, University of Health Sciences, Lahore, Pakistan. She also took part in the “Perspective & Dimensions of Drug Product Bioequivalence in the 21st Century” event, organized by the University of Karachi in December 2015

CONFERENCES & WORKSHOPS

She has actively participated in various conferences and workshops to enhance her professional development. In 2016, she attended a workshop on “Coaching Conversation Approaches for the Workplace” at Prince Sattam Bin Abdul Aziz University. She also participated in the conference on “WHO Prescribing Indicators & Its Compliance by General Practitioners of Lahore, Pakistan,” conducted by the 4th China Pharmaceutical University International Students Academic Forum at the Conference Center Jiangning Campus in April 2017. She attended the PPA International Conference Seminar on “Pharmacists Voice: Patient Safety Starts with Me” at the University of Central Punjab, Pakistan. Additionally, she was involved in the 3rd Annual Conference of Rashid Latif College of Pharmacy, held at Rashid Latif Medical College, University of Health Sciences, Lahore, Pakistan. She also took part in the “Perspective & Dimensions of Drug Product Bioequivalence in the 21st Century” event, organized by the University of Karachi in December 2015

CITATIONS RESEARCH GATE

  • Research Interest Score – 1151
  • Citations –  1508
  • h-Index –    23

CITATION GOOGLE SCHOLAR:

  • Citations –   1516
  • h- Index –      22
  • i-10 Index –    47

Book Chapters:

  1. F Islam, MR Islam, MH Nafady, M Faysal, SL Khan, M Zehravi, Pharmacogenomics of immunosuppressants, Publisher: Elsevier Inc. Pharmacogenomics, 323-344, 2023/11. Academic Press
  2. Karthika, C. et al. (2023). The Role of Curcumin as an Anti-Aging Compound. In: Rizvi, S.I. (eds) Emerging Anti-Aging Strategies. Online 31st January 2023, Springer, Singapore.
  3. Entitled – Basic Laboratory Methods of Pharmacology & Toxicology, Published in Sept 2021, ISBN-976-81-7622-495
  4. C Karthika, M Zehravi, R Akter, MH Rahman, Stretegic design of Nano carrier system for Nutraceutical, CRC Press, Handbook of Nanotechnology in Nutraceuticals, 79-96
  5. Entitled – Pharmacophore Modelling & its significance in Drug Discovery, CRC Press Nanotechnology in Nutraceuticals, Feb 2022, Accepted by the Editor, accepted for the publication.

Publications Top Noted

 

Stanley Nkemjika | Medicine and Dentistry| Best Researcher Award

Published on by Shen Awards

Dr. Stanley Nkemjika | Medicine and Dentistry| Best Researcher Award

Thomas Jefferson University, United States

He has held a variety of roles in the medical and academic fields over the years. From 2023 to 2024, he served as a Psychiatry Attending at both St. Joseph Medical Center, Yonkers, NY, and the Psychiatry ER Department of Psychiatry and Behavioral Sciences at Interfaith Medical Center, Brooklyn, NY. Additionally, he was the Chief Resident in the Department of Psychiatry and Behavioral Sciences at Interfaith Medical Center, One Brooklyn Health System, Brooklyn, NY. He has been a Psychiatry Resident at the same department since 2020. Prior to this, he worked as a Graduate Research Assistant at Georgia State University’s Department of Population Health (2019-2020) and at Georgia Southern University’s Department of Epidemiology (2018-2019). He also served as a Course Instructor at the Graduate School of Biomedical Sciences, Robert Wood Johnson Medical School, Rutgers University, from 2015 to 2018, and as a Research Associate at University Behavioral Health Care, Rutgers University, from 2013 to 2015. Earlier in his career, he worked as a Primary Care Physician in Nigeria, first at the Department of State Services Medical Center, Office of the Presidency (2010-2013), and then at the Department of Family Medicine, National Hospital, Office of the Presidency (2008-2010). He began his medical career as a Medical Intern at the University College Hospital in Ibadan in 2007-2008.

Professional Profile

Education

He has an extensive educational background in medicine and public health. He completed his Psychiatry Residency at the Department of Psychiatry and Behavioral Sciences, Interfaith Medical Center, One Brooklyn Health System, Brooklyn, NY, from 2020 to 2024. Before that, he was a Post-Doctoral Research Fellow in Global Mental Health at the Office of Global Health, Robert Wood Johnson Medical School, Rutgers University, from 2015 to 2018. In 2015, he earned a Master of Public Health (MPH) degree from the Department of Epidemiology, School of Public Health, Rutgers University. He obtained his Medical Doctor (MD) degree in 2007 from the College of Medicine, University of Ibadan.

Professional Experience

He has held several teaching positions in academia over the years. From 2019 to 2021, he was a Course Instructor for PH8721 Chronic Disease Epidemiology in the Department of Population Health, School of Public Health, Georgia State University, Atlanta, GA. In 2019, he also served as a Teaching Assistant for Research Methods II at the same institution. Prior to this, from 2014 to 2018, he was the Course Director for MSBS 5080S Primer on Global Health at the Graduate School of Biomedical Sciences, Robert Wood Johnson Medical School, New Brunswick, NJ.

 

Award and Honor

He has received several academic honors and awards throughout his career. In 2023, he was awarded second prize recognition for excellence in research by the Brooklyn Psychiatry Society. The previous year, in 2022, he earned the Underrepresented Minority Research Scholarship from the American Association of Addiction Psychiatry. In 2019, he was named a Second Century Initiative Research Fellow at Georgia State University. In 2015, he received the Community Service Award from the School of Public Health, Rutgers University. Earlier in his career, he was honored with the Postgraduate Scholarship Award from the Niger Delta Development Commission, Ministry of Niger Delta Affairs, Nigeria, in 2012. Additionally, in 2007, he was presented with the Academic Excellence and Leadership Award by the Ibadan College of Medicine Alumni Association at the College of Medicine, University of Ibadan.

 

Publications Top Noted
  • Brown C, Nkemjika S, Yankey B, Okosun I. Alternative Tobacco Product Use and Smoking Quit Attempts Among Teenagers in the United States: A Cross-Sectional Study. Cureus. 2021 Jul 29;13(7):e16740. doi: 10.7759/cureus.16740. PMID: 34471583; PMCID: PMC8403058.Pub Status: Published.
  • Atolagbe A, Nkemjika S, Popoola O, Oladeji O, Kogan I, Saeed H, Olupona T. Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review. Case Rep Psychiatry. 2021 Aug 17;2021:3980872. doi: 10.1155/2021/3980872. PMID: 34447597; PMCID: PMC8384506.Pub Status: Published.
  • Nkemjika S, Tokede O, Jadotte Y, Olatunji E, Bosah J, Pigott T, Okosun IS. Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: a systematic review protocol. JBI Evid Synth. 2021 Jul 13. doi: 10.11124/JBIES-20-00277. Epub ahead of print. PMID: 34261092., Pub Status: Published.
  • Okosun IS, Nkemjika S, Okosun B, Lyn R, Airhihenbuwa CO. Lifestyle Modification Practices and Drug Prescription Use in Elderly Americans with Metabolic Syndrome: A Nationwide Population-Based Study [published online ahead of print, 2020 Jul 5]. J Natl Med Assoc. 2020;S0027-9684(20)30127-9. doi:10.1016/j.jnma.2020.06.008, Pub Status: Published.
  • Twum F, Morte N, Wei Y, Nkemjika S, Liu F, Zhang J. Red blood cell folate and cardiovascular deaths among hypertensive adults, an 18-year follow-up of a national cohort [published online ahead of print, 2020 Jun 11]. Hypertens Res. 2020;10.1038/s41440-020-0482-5. doi:10.1038/s41440-020-0482-5, Pub Status: Published.
  • Nkemjika S, Ifebi E, Cowan LT, et al. Association between serum folate and cardiovascular deaths among adults with hypertension. Eur J Clin Nutr. 2020;74(6):970-978. doi:10.1038/s41430-019-0533-7, Pub Status: Published.
  • Nkemjika, S.O., &Demissie, K. Breast feeding initiation time and its impact on diarrheal disease and pneumonia in West Africa. Journal of Public Health and Epidemiology. 2015, Dec; 7(2141- 2316): 352- 359. Cited in PubMed; PMID: JPHE., Pub Status: Published.
  • Nkemjika, S.O., &Taherisefat, M., & West, B., &Tokede, O.. Impact of violence on child growth and youth development: Newark, New Jersey study. International Journal of Current Research. 2016, Apr; 8(0975- 833X): 29695- 29700. Cited in PubMed; PMID: IJCR., Pub Status: Published.
  • Owolabi, W., &Davidow, A., & Thomas, P., & Mangala, R., &Nkemjika, S., &Tokede, O.. Relationship between ambient Air pollution (pm 2.5) and low birth weight deliveries in New Jersey. International Journal of Current Research. 2016, Jun; 8(0975- 833X): 33372- 33378. Cited in PubMed; PMID: IJCR, Pub Status: Published.

Junjie Liu | pharmaceutics | Best Researcher Award

Published on by Shen Awards

Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Profile

Education🎓 

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫 

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬 

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.

 

Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile
Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

  • Journal: International Journal of Molecular Sciences
  • Date: September 26, 2023
  • DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

 

Dr. Nasim Mayeli | cell therapy | Best Researcher Award

Published on by Shen Awards

Dr. Nasim Mayeli | cell therapy | Best Researcher Award

Research Assistant at cell therapy , Shahid chamran university, Iran

Nasim Mayeli Fereydani earned her Ph.D. in Molecular Genetics from Shahid Chamran University in Ahvaz, Iran. Her doctoral research, conducted from 2016 to 2024, centered on correcting the Beta-globin CD36/37(-T) mutation in human hematopoietic stem cells using the CRISPR/Cas9 platform. Dr. Fereydani’s work was conducted under the guidance of Dr. Hamid Galehdari, a Professor in Molecular Genetics.

Professional Profiles:

EDUCATION:

Nasim Mayeli Fereydani has a diverse academic background, starting with a B.Sc. in Microbiology from Shahid Chamran University in Ahvaz, Iran, completed from 2003 to 2007. She then pursued an M.Sc. in Microbiology at the same university, completing her thesis on the isolation of polyhydroxyalkanoates-producing bacteria from contaminated soil of Bandar Imam Petrochemical Industries under the supervision of Dr. Hossein Motamedi, a Professor in Microbiology, from 2009 to 2012. Nasim furthered her studies with a Ph.D. in Molecular Genetics at Shahid Chamran University, focusing her research on correcting the Beta-globin CD36/37(-T) mutation in human hematopoietic stem cells using the CRISPR/Cas9 platform. Her doctoral thesis was supervised by Dr. Hamid Galehdari, a Professor in Molecular Genetics, and she completed her Ph.D. from 2016 to 2024.

WORK EXPERIENCE:

Nasim Mayeli Fereydani has been actively involved in various educational, community, clinical, and research activities. As a Lecturer at Islamic Azad University Ahvaz Branch from 2021 to 2023, she taught courses on Principles of Genetics, Cancer Genetics, Genetic Engineering Laboratory, Basic Genetic Laboratory, and Cell Culture. In addition, she participated in professional community activities, focusing on disability awareness and prevention plan and familiarization with genetic counseling for students of Ahvaz, Iran-National Welfare Organization, from 2017 to 2018. In clinical settings, Nasim worked at Ghandil Medical Genetics Laboratory from 2013 to 2017. She served as the Supervisor and technical technician of the prenatal diagnostic of thalassemia department from 2015 to 2017, the technical technician of the molecular department from 2014 to 2017, and the technical technician of the cytogenetics department, involved in karyotyping, from 2013 to 2014. Furthermore, Nasim was a Research Assistant at Ahvaz Jundishapur University of Medical Sciences from 2011 to 2013. She collaborated on research projects in the faculty of medicine, department of immunology, student and research projects in the faculty of dentistry, and the research project of the thalassemia & hemoglobinopathy research center from 2019 to 2023.

SKILLS:

Nasim Mayeli Fereydani has a wide range of skills in both wet and dry lab techniques. In the wet lab, she is proficient in DNA and RNA extraction from various sources, including blood, cell lines, and bacteria. She has expertise in various PCR techniques, such as Conventional PCR, Real-time PCR (SYBR Green -TaqMan), ARMS-PCR, Multiplex-PCR, and PCR-RFLP. Nasim is also skilled in electrophoresis using agarose gel and Polyacrylamide (PAGE), with experience in silver nitrate staining. She is knowledgeable in cloning methods, including Conventional cloning and TA-cloning, as well as gene editing using CRISPR/Cas9. Nasim has experience in bacterial culture, mammalian cell culture (including cancer cell lines like A549, MCF7, HepG2, and HEK293T), and stem cell culture (isolating mesenchymal stem cells from various tissues and hematopoietic stem cells using immunomagnetic separation). She is also familiar with flow cytometry (sample preparation, instrument setting, and data analysis using FlowJo), fluorescent microscopy, cell transfection methods (Nucleofection and polyethylenimine), and laboratory animal handling (injection of cancer cells to create mouse models).  In the dry lab, Nasim is skilled in primer and probe design for guide RNA and Donor DNA, statistical analysis using SPSS, and proposal writing.

PUBLICATIONS:

Mayeli N, Motamedi H, Heidarizadeh F. “Production of Polyhydroxybutyrate by Bacillus axaraqunsis BIPC01 using Petrochemical Wastewater as Carbon Source.” Braz arch biol technol. 2015:643-50

Motamedi H, Roayaee Ardakani M, Mayeli N. “Isolation and screening of native polyhydroxyalkanoate producing bacteria from oil contaminated soils of Abadan refinery.” Biological Journal of Microorganism. 2015;3(12):93-104.

Mayeli N, Galehdari H, Hoveizi E, Ajami M. “A comparison of the efficiency of the T7-Endonuclease I enzyme and polyacrylamide gel electrophoresis system in evaluating the cleavage efficiency of the CRISPR/Cas9 system.” Journal of Isfahan Medical School. 2024.

Mayeli N, Galehdari H, Hoveizi E, Ajami M, Alghasi A. “Ex vivo expansion of Hematopoietic stem cells in two/three-dimensional co-cultures with various sources of stromal cells.” Tissue and Cell journal, 2024 (accepted/in press).

“Genetic correction of CD 36/37 (-T) β-thalassemia mutation by CRISPR/Cas9 in human hematopoietic stem cells as a common mutation of southwest of Iran” (under preparation).

 

 

Assoc Prof Dr. Shimaa Ramadan Emam | Pharmacology | Scientific Excellence Achievement Award

Published on by Shen Awards

Assoc Prof Dr. Shimaa Ramadan Emam | Pharmacology | Scientific Excellence Achievement Award

Pharmacology at , Cairo university, Egypt

👨‍🎓She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Assoc Prof Dr. Shimaa Ramadan Emam has completed a Bachelor of Veterinary Medicine (BVM) in May 2008 from the Faculty of Veterinary Medicine at Cairo University, Egypt, with a very good honor grade. Additionally, they obtained a Master of Sciences (M.S.) in Pharmacology from the Department of Veterinary Pharmacology at Cairo University, Egypt, in May 2011. Their master’s dissertation was titled “Pharmacological studies on Silybum marianum and Marjorana hortensis plants.” They have also completed various courses with excellent grades, including Physiology, Metabolism, and Energy (0028), Special Bacteriology (0073), Advanced Biostatistics (00192), Methods of Research (00800), and Veterinary Pharmacology (0090).

Professional Experience:

Assoc Prof Dr. Shimaa Ramadan Emam has been an Associate Lecturer of Pharmacology at the Faculty of Veterinary Medicine, Cairo University, since 2020. Prior to this, they served as a Lecturer of Pharmacology at the same institution from 2015 to 2020. From 2008 to 2015, they worked as a Research and Teaching Assistant at the Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. Additionally, they held the position of Demonstrator at the Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt, from 2007 to 2008.

Webinarand Conferences:

The 7th International Conference of the Faculty of Veterinary Medicine, Cairo University (VETCU 2018), which focused on “One Health: Animal, Human, Environment Recent Applications,” held from August 5th to 8th, 2018. They were involved in attendance, participation, and organization of the event. A webinar titled “Enhance Your Research with Elsevier: Discover Research Metrics on and Updated Citescore and Quartiles.” A regional conference on the implementation of international research animal care practices, which took place in Cairo, Egypt, from April 22nd to 24th, 2018. The International Egyptian CZECH Conference on Nanotechnology Applications held at Cairo University on October 10th and 11th, 2017. A webinar focusing on novel approaches in pharmaceutical sciences researches confronting COVID-19, specifically addressing natural products for pandemic control. The 65th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics (ESPET), which included a workshop on behavioral pharmacology held at the British University in Egypt on January 28th, 2017.

Conferences:

Assoc Prof Dr. Shimaa Ramadan Emam attended the 6th scientific conference, “A Healthy Animal for a Safe Diet,” in Cairo – Hurghada from August 27th to 31st, 2013. They also participated in the 8th scientific conference, “Animal Health, Poultry & Community Health,” held in Cairo – Hurghada from August 23rd to 27th, 2016.

Research Interest:

Pharmacological evaluation of newly synthesized chemical compounds. Pharmacological screening of medicinal plants. Microbiological screening of plant extracts. Biological activity-guided separation and isolation of bioactive compounds from plants using different chemical and chromatographic techniques. Studying drug-drug interactions and drug-herb interactions.

Skills and Techniques:

Assoc Prof Dr. Shimaa Ramadan Emam has significant experience in using various statistical programs, such as SPSS and pharmacokinetic programs. They also possess a wide range of technical skills, including expertise in techniques like High-Performance Liquid Chromatography (HPLC), High-Performance Liquid Chromatography Mass Spectrophotometry (HPLC-MS), Microbiological Assay, Spectrophotometry, and Ultrasonography. Moreover, they are familiar with planning and have technical expertise in executing in vivo protocols to conduct studies. This includes tasks like in vivo dosing and sample preparation for analysis, in vivo disease model development, scheduling and overseeing Pharmacokinetic (PK) studies, and analyzing results. Additionally, they are proficient in preparing detailed experimental records, summaries, and technical reports.

Language Skills:

Assoc Prof Dr. Shimaa Ramadan Emam is fluent in Arabic, their mother tongue, and possesses excellent reading and writing skills in both Arabic and English. They are proficient in using computer software, including Microsoft Office (Word, Excel, PowerPoint), Photoshop, and Adobe Acrobat. Their experience with these programs indicates a strong familiarity with computer writing skills.

Awards Special Experience:

Assoc Prof Dr. Shimaa Ramadan Emam  has received international publication awards from Cairo University in both 2020 and 2021. They are experienced in planning and executing in vivo protocols, conducting studies such as in vivo dosing and sample preparation for analysis, developing in vivo disease models, scheduling and overseeing pharmacokinetic (PK) studies, and analyzing the results. Additionally, they are skilled in preparing detailed experimental records, summaries, and technical reports.

Publications:

Optimization of an Off-Grid PV/Biomass Hybrid System with Different Battery Technologies

  • Published in Energy in 2018 with 197 citations.

A flower pollination optimization algorithm for an off-grid PV-Fuel cell hybrid renewable system

  • Published in Energy in 2019 with 179 citations.

Multi-Objective Optimization of Grid-Connected PV-Wind Hybrid System Considering Reliability, Cost, and Environmental Aspects

  • Published in Energy in 2020 with 165 citations.

Techno-economic analysis for rustic electrification in Egypt using multi-source renewable energy based on PV/ wind/ FC

  • Published in Energy in 2020 with 144 citations.

Optimal economic study of hybrid PV-wind-fuel cell system integrated to unreliable electric utility using hybrid search optimization technique

  • Published in Energy in 2021 with 128 citations.

Multi-objective optimization of hybrid renewable energy system based on biomass and fuel cells

  • Published in Energy in 2021 with 66 citations.

A Techno-Economic Feasibility Analysis of an Autonomous Hybrid Renewable Energy Sources for University Building at Saudi Arabia

  • Published in Energy in 2020 with 63 citations.

Feasibility Study of Grid Connected PV-Biomass Integrated Energy System in Egypt

  • Published in Energy in 2016 with 62 citations.

 

Mr. Waseem Ali | Drug Repurposing | Best Researcher Award

Published on by Shen Awards

Mr. Waseem Ali : Leading Researcher in Drug Repurposing

PhD Student at Drug Repurposing, Guru Nanak Dev Engineering College, Ludhiana, Punjab, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Waseem Ali achieved academic success throughout his educational journey. In 2011, he secured a First Division in the Matriculation examination from the C.B.S.E. Board, India, with a focus on Science. Continuing his impressive performance, he obtained a Second Division in the Higher Secondary examination in 2013 from the same board. In 2016, he graduated with a Second Division from C.C.S. University, Meerut, specializing in Biotechnology with a focus on molecular biology. His commitment to excellence was further demonstrated in 2018 when he completed his Post Graduation with a First Division from Jamia Hamdard, New Delhi, specializing in Biotechnology with a focus on molecular biology.

Experience:

Mr. Waseem Ali has held several positions in the field of Biotechnology and molecular biology. From 05-08-2022 to 29-12-2022, he served as a Project Assistant at Jamia Hamdard, where he contributed to a project aiming to decipher novel targets of M.tb pathogenesis that manipulate host defenses in compromised hosts. The identified targets may be utilized to develop anti-TB agents effective against drug-resistant isolates. His supervisor during this time was Dr. Javaid A Shaikh. Prior to this, from 15-01-2019 to 04-08-2022, Mr. Ali worked as a Project Assistant at Jamia Hamdard, focusing on determining the effect of FDA-approved drugs against M.tb. He evaluated the efficacy of selected drugs against M.tb in vitro and ex vivo, using molecular docking, simulation, and biophysical methods to predict their binding affinity and effect with target proteins. His supervisors during this period were Prof. S. E. Hasnain and Dr. Sonam Grover. Currently, since 04-01-2021, Mr. Ali is pursuing his Ph.D. at Jamia Hamdard under the guidance of Prof. S. E. Hasnain and Dr. Sonam Grover, focusing on research related to drug repurposing.

Publications:

Mr. Waseem Ali has co-authored several research papers in reputable journals. In “Microbes and Infection” in 2023, he collaborated with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Isha Pahuja, Rahul Sharma, Ved Prakash Dwivedi, Meetu Agarwa, and Sonam Grover on a paper titled “Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA,” which was published on 5.8. In “Molecular Informatics” in 2023, he worked with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Rahul Sharma, Meetu Agarwal, Javaid Ahmad Sheikh, Abhinav Grover, and Sonam Grover on a paper titled “Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors,” which was published on 4.05. Additionally, in “Computational and Structural Biotechnology Journal” in 2021, he contributed to a paper titled “Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis,” co-authored with Pooja Singh, Salma Jamal, Faraz Ahmed, Najumu Saqib, Seema Mehra, Deodutta Roy, Nasreen Z Ehtesham, and Seyed E Hasnain. In “Journal of Translational Medicine” in 2021, Mr. Ali collaborated with Salma Jamal, Priya Nagpal, Abhinav Grover, and Sonam Grover on a paper titled “Computational models for the prediction of adverse cardiovascular drug reactions,” which was published on 8.44.

 

Mr. Zaid Khan | Clinical Pharmacist | Young Scientist Award

Published on by Shen Awards

Mr. Zaid Khan : Leading Researcher in Sensing

Research Intern at Clinical Pharmacist, Aditya banglore institute of pharmacy education and research, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Zaid Khan is currently pursuing his Doctor of Pharmacy (19Q0088) at Aditya Bangalore Institute of Pharmacy Education and Research, located in Yelahanka, Bangalore, Karnataka (K.A). This program is approved by the Pharmacy Council of India and AICTE and is affiliated with Rajiv Gandhi University of Health Sciences and the Government of Karnataka. Throughout his academic journey, Mr. Khan has consistently achieved distinction and first-class grades in all four years of his program, maintaining an overall percentage. Before his doctoral studies, he completed his PUC (Preuniversity college) in PCMB (Physics, Chemistry, Mathematics, Biology) from Jnana Bandhu PU college, Pandavapura, Mandya Dt, K. A, achieving a score of 60% in 2019. Additionally, he completed his SSLC (Secondary School Leaving Certificate) from Vijaya Composite Junior College, Pandavapura, Mandya Dt, K. A, with a score of 70% in 2017 under the Karnataka Secondary Education Examination Board (KSEEB).

Work Experience:

Mr. Zaid Khan has gained valuable experience in clinical pharmacy through rotations at Akash Hospital in Devanahalli, Bangalore. During this time, he actively engaged in patient counseling, conducted thorough drug interaction checks, monitored adverse drug reactions, and contributed to medical writing. This hands-on experience has honed his skills in ensuring pharmaceutical care and patient safety, contributing to improved patient outcomes, and furthering his professional development in the field of clinical pharmacy.

Career:

Mr. Zaid Khan is a dedicated and accomplished Pharm D researcher with a strong foundation in pharmaceutical sciences and clinical pharmacy. He is seeking a challenging position to apply his research expertise, knowledge, and skills to contribute to advancements in the field. Mr. Khan has a track record of successfully completing and publishing research projects in national and international journals, demonstrating his wealth of experience in diverse therapeutic and research areas. His commitment to continuous learning is evident through his active participation in both online and offline conferences, workshops, and webinars, where he engages with cutting-edge research topics. Clinically, he is developing skills as a Pharm D, enhancing his ability to bridge the gap between research and practical applications in the pharmaceutical landscape. Mr. Khan is eager to leverage his knowledge and passion for research in a dynamic environment that fosters innovation and encourages professional growth.

Research and Awards:

Mr. Zaid Khan has participated in various academic and research activities, demonstrating his commitment to professional development and contribution to the field of pharmacy. He participated in a National Level Essay Writing Competition in 2023 on “Pharmacy in the Digital Age: Addressing Challenges and Embracing Opportunities,” receiving a Certificate of Participation from Chalapathi Institute of Pharmaceutical Sciences (Autonomous), Sanjivani College of Pharmaceutical Education and Research (Autonomous), and Pharmacy Teachers Trust (Andhra Pradesh and Telangana). Additionally, he presented a poster on “A Retrospective Study on Comprehensive Assessment of Leprosy in Bangalore District” and received a Certificate of Appreciation from RR College of Pharmacy at a national conference called RR Chemcol-2023, in association with Karnataka State Pharmacy Council. Furthermore, Mr. Khan presented a poster on “Evaluation of Photoprotection and Sunscreen Activity of Selected Natural Plant Substances viz Beta vulgaris, Linium, Linum Usitatissimum, Camellia sinensis, In vitro Sun Protection Factor Determination,” for which he was awarded Best Poster Presenter by the Institution’s Innovative Council of Aditya Group of Institutions, organized by the Indian Science Congress Association – Bangalore Chapter.

Conferences:

Mr. Zaid Khan has been actively involved in several international and national conferences, demonstrating his engagement in current issues and trends in the field of pharmacy and healthcare. He participated in a virtual event titled “Have We Reached the Breaking Point? Rising Chronic Illness, Emotional Distress, and Pain in the Era of COVID-19 and the Environmental Crises,” organized by Arizona State University (U.S.), for which he was awarded a Participation E-Certificate. Additionally, he attended the 4th World Congress on Drug Discovery and Development-2023, an International Conference held offline, and received a Participation Certificate from Biogenesis Health Cluster at J.N Tata Auditorium, Indian Institute of Science, Bengaluru, India. He also participated in a virtual event on “Exploring the Potential of Ayurveda in Promoting the Well-Being of Human Being, Animals’ Environment, Plants, and Animals,” organized by South Kazakhstan Medical Academy, Kazakhstan, and JSS Academy of Higher Education and Research, Mysuru, India, for which he received a Participation Certificate. Furthermore, Mr. Khan was awarded a Participation Certificate by SYCOON-23, organized by PharmD Students Network of Rx Doctors, for his participation in the National Conference on “Steer Your Career Series 2 Episode 9.”